Prostate specific antigen bounce is related to overall survival in prostate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 883-888

  Hinnen, Karel A ^a   Monninkhof, Evelyn M ^a   Battermann, Jan J ^a   Van Roermund, Joep G H ^a   Frank, Steven J ^b   Van Vulpen, Marco ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bounce; Brachytherapy; Prostate cancer; PSA spike; Transient PSA elevation

Indexed keywords

AFTER-TREATMENT; BIOCHEMICAL FAILURE; BOUNCE; BRACHYTHERAPY; CONFIDENCE INTERVAL; COX REGRESSION ANALYSIS; DISEASE-SPECIFIC SURVIVALS; FREEDOM FROM BIOCHEMICAL FAILURES; GLEASON SCORES; HAZARD RATIO; MONO-THERAPY; OVERALL SURVIVAL; OVERALL SURVIVAL RATES; PROSTATE BRACHYTHERAPY; PROSTATE CANCER; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; PSA SPIKE;

ANTIGENS; ONCOLOGY; PATIENT MONITORING; RADIOTHERAPY; REGRESSION ANALYSIS;

DISEASES;

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ADULT; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE BRACHYTHERAPY; PROSTATE CANCER; RISK REDUCTION; TRANSURETHRAL RESECTION;

AGED; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84855824396     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.11.049     Document Type: Article

References (22)

1. M. Roach 3rd, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO phoenix consensus conference Int J Radiat Oncol Biol Phys 65 2006 965 974
2. F. Akyol, G. Ozyigit, and U. Selek PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone Eur Urol 48 2005 40 45
3. P. Das, M.H. Chen, and K. Valentine Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce Int J Radiat Oncol Biol Phys 54 2002 698 702
4. A.F. Prestigiacomo, and T.A. Stamey Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng./ml. range in male volunteers J Urol 155 1996 1977 1980
5. C. Patel, M.A. Elshaikh, and K. Angermeier PSA bounce predicts early success in patients with permanent iodine-125 prostate implant Urology 63 2004 110 113
6. J.P. Ciezki, C.A. Reddy, and J. Garcia PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time Int J Radiat Oncol Biol Phys 64 2006 512 517
7. R.G. Stock, N.N. Stone, and J.A. Cesaretti Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: Descriptions and implications Int J Radiat Oncol Biol Phys 56 2003 448 453
8. G.S. Merrick, W.M. Butler, and K.E. Wallner Prostate-specific antigen spikes after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 54 2002 450 456
9. C. Bostancic, G.S. Merrick, and W.M. Butler Isotope and patient age predict for PSA spikes after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 68 2007 1431 1437
10. R. Nath, L.L. Anderson, and G. Luxton Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM radiation therapy committee task group no. 43 Med Phys 22 1995 209 234
11. J.J. Battermann, T.A. Boon, and M.A. Moerland Results of permanent prostate brachytherapy, 13 years of experience at a single institution Radiother Oncol 71 2004 23 28
12. K.A. Hinnen, J.J. Battermann, and J.G. van Roermund Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 76 2009 1433 1438
13. D. Ash, A. Flynn, and J. Battermann ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer Radiother Oncol 57 2000 315 321
14. K. Komatsu, N. Wehner, and A.F. Prestigiacomo Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population Urology 47 1996 343 346
15. C. Sheinbein, B.S. Teh, and W.Y. Mai Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancer Urology 76 2010 728 733
16. W. Cavanagh, J.C. Blasko, and P.D. Grimm Transient elevation of serum prostate-specific antigen following (125)I/(103)pd brachytherapy for localized prostate cancer Semin Urol Oncol 18 2000 160 165
17. F.A. Critz, W.H. Williams, and A.K. Levinson Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: The relationship to patient age J Urol 170 2003 1864 1867
18. J.W. Denham, A. Steigler, and C. Wilcox Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: Evidence from the TROG 96.01 randomised controlled trial Lancet Oncol 9 2008 1058 1068
19. F.A. Critz, W.H. Williams, and J.B. Benton Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer J Urol 163 2000 1085 1089
20. E.M. Roeloffzen, I.M. Lips, and M.P. van Gellekom Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer Int J Radiat Oncol Biol Phys 76 2010 1054 1060
21. C.J. Rosser, A.M. Kamat, and X. Wang Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer? Urology 66 2005 327 331
22. A. Kirilova, A. Damyanovich, and J. Crook 3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following (125)iodine brachytherapy Int J Radiat Oncol Biol Phys 79 2 2011 Feb 1 371 378